Engineering TCR-controlled fuzzy logic into CAR T cells enhances therapeutic specificity
{{output}}
Chimeric antigen receptor (CAR) T cell immunotherapy represents a breakthrough in the treatment of hematological malignancies, but poor specificity has limited its applicability to solid tumors. By contrast, natural T cells harboring T cell receptors (TCRs) ca... ...
